S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 94 900 KRW 0.74% Market Closed
Market Cap: 1.9T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ST Pharm Co Ltd
Net Income (Common) Peer Comparison

Comparables:
207940
F
220100
L
141080
C
268600
E
456070

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Net Income (Common)
â‚©21.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Net Income (Common)
â‚©1T
CAGR 3-Years
45%
CAGR 5-Years
34%
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Net Income (Common)
-â‚©8.7B
CAGR 3-Years
19%
CAGR 5-Years
3%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Net Income (Common)
-â‚©33.9B
CAGR 3-Years
3%
CAGR 5-Years
-7%
CAGR 10-Years
-18%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Net Income (Common)
-â‚©8.7B
CAGR 3-Years
25%
CAGR 5-Years
12%
CAGR 10-Years
N/A
E
ENCell Co Ltd
KOSDAQ:456070
Net Income (Common)
-â‚©5.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ST Pharm Co Ltd's Net Income (Common)?
Net Income (Common)
21.7B KRW

Based on the financial report for Jun 30, 2024, ST Pharm Co Ltd's Net Income (Common) amounts to 21.7B KRW.

What is ST Pharm Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
22%

Over the last year, the Net Income (Common) growth was 22%.

Back to Top